Viola Odorata Homeopathic Medicine Recall for Failed Identification Testing
Washington Homeopathic Products is recalling Viola Odorata homeopathic medicine (Lot #29057, expiration 8/17/2026) distributed nationwide because identification testing using HPTLC analysis returned out-of-specification results.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class II recall. The source text identifies a quality-control issue (failed identification testing) but does not report any illnesses, injuries, or hospitalizations, making this a precautionary recall without evidence of patient harm.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Viola Odorata 4X, 10X, and 12X homeopathic medicine pills (sucrose/lactose base) distributed nationwide in the United States. The recall affects Lot #29057 with an expiration date of 8/17/2026, packaged in 2-dram and 4-dram bottles.
The recall was initiated because identification testing using high-performance thin-layer chromatography (HPTLC) analysis produced results that did not meet specification standards.
Consumers who have purchased this product should stop use and consult their healthcare provider if they have questions about their use of the recalled product.
The recalled product
- Product
- Viola Odorata 4X, 10X, 12X, Bee Stings*, Sucrose/Lactose Pills, 4X Packaged in a) 2 Dram; 10X Packaged in b) 2 Dram; 12X Packaged in c) 2 Dram; d) 4 Dram; WHP Homeopathic Medicine, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV, 25411.
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic
- Hazard
- failed-identification-testing
- out-of-specification
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 29057
- Exp 8/17/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27